Abstract
Pancreatic cancer is associated with poor prognosis and surgery remains the main modality of treatment. Negative resection margin is an important prognostic factor for survival. Retropancreatic margin or the medial margin is the most common site of positive resection margin. Mesopancreas was proposed in analogy with mesorectum, which is considered as a fusion fascia formed embryologically during the development of pancreas. This mesopancreas lies posterior to the pancreas and contains pancreaticoduodenal vessels, lymphatics, nerve plexus and loose areolar tissue. Various technical modifications were proposed for better dissection of mesopancreas like posterior approach and artery first approach. There is an increased rate of R0 resection by these technical modifications but whether this will turn to increase in survival rates is yet to be established.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Pancreatic cancer is one of the rare gastrointestinal cancer with worst prognosis and the age adjusted incidence rate is 1/1, 00,000 population [1]. Complete surgical resection with R0 negative margins leads to 5 year survival rate of 5 to 20 %. Various studies showed the rate of noncurative resections of 15–35 % [2–5], but with modified pathological examination (R1/R2) revealed the rate of R1 resection was higher ranging from 76–85 % [6–9]. Also autopsy studies in patients who died with pancreatic cancer showed 100 % local recurrence. Even patients with R0 resection had local recurrence which lead surgeons to attempt more radical approaches like regional pancreatectomies and extended lymphadenectomies. Fortner proposed regional pancreatectomies which initially showed promising results but follow up long term studies showed poor results [10]. Whether this discrepancy was caused by incomplete lymphnode dissection, perineural dissection and improper pathological examination was not yet known. Perineural invasion was detected in 77 % of specimens of resected pancreatic cancers [11].
Total mesorectal excision introduced by Heald’s in treatment of rectal cancer lead to the path in applying the anatomical knowledge to help in better surgical resection. By dissecting in a plane between the fascia propria and presacral fascia, mesorectum was excised and had decreased the risk of local recurrence [12]. This concept of applied embryology and anatomy was introduced to various organs to increase rate of negative margins of resection. Mesopancreas, mesogastrium, mesoesophagus, mesohepatectomy and mesometria were described based on postulates in analogy with mesorectum [13–17]. Whether these descriptions and further refinement in surgical technique based on these postulates will give better results or not is not yet known.
Embryology
The pancreas develops from 2 buds one in the vental mesogastrium which is the ventral bud and the other in the dorsal mesogastrium which is called as dorsal bud on the lateral aspect of duodenum. They receive blood supply from the gastroduodenal artery a branch of common hepatic artery, inferior pancreaticoduodenal artery a branch of Superior mesenteric artery (SMA) and splenic artery. The ventral bud rotates and fuses with dorsal bud to form the pancreas (Fig. 1). The duct of dorsal bud forms the accessory duct or duct of santorini. Duct of wirsung is formed proximally by the ventral pancreatic duct and the distally by the dorsal pancreatic duct (Fig. 2) [18].
Anatomy
Pancreas is related anatomically with the duodenum, kidneys and major vessels. Kidneys are covered by Gerotas fascia which constitutes anterior layer called as fascia of Toldts and a posterior lamina called as fascia of Zuckerkandl. The posterior lamina unites with anterior lamina close to the colon to form lateroconal fascia. Medially the extent of anterior lamina is doubtful with varying reports. The sheet of tissue behind the duodenum and pancreas formed by the fusion of embryological mesoduodenum with posterior abdominal wall after rotation lead to the formation of retroduodenopancreatic fascia of Treitz and was first described in 1853. The fusion fascia of the body and tail of pancreas due to fixation of dorsal wall of lesser sac was called as Toldt’s fascia (Fig. 2). Pancreaticoduodenal arcades of arteries, veins and nerves are situated on the fusion fascia of treitz. This fascia also covers the extrapancreatic nerve plexus, superior mesenteric artery and portal vein [19]. Pancreatic cancer of head hence follows these arteries, veins, nerves and spread horizontally towards the SMA or celiac axis rather than posteriorly towards inferior vena cava (IVC). This soft tissue between the pancreatic head and SMA includes nerves, vessels, lymphatics and nodes which is called as the mesopancreas [13] (Fig. 3). But a cadaveric study failed to show a fascial covering over these structures [20]. The previous terminology used for mesopancreas include retroportal lamina or retroportal pancreas [21]. Some authors proposed that a total mesopancreatic excision for better achievement of curative (R0) resection [22].
Review of Literature
A literature search on “mesopancreas” and “retroportal lamina” in Pubmed on July 2008 revealed 15 published articles of which 8 articles are reviewed which are related to the present subject (Table 1). Pancreaticoduodenenctomy procedure was first published by Codvilla in 1898 [23]. Kausch and Whipple popularized the procedure of pancreaticoduodenectomy [24, 25]. Later more than 70 technical modifications have been described in literature most of them on the techniques of reconstruction [26]. Though the postoperative mortality had decreased from 20 % to 5 % in most of the centers, the 5 year survival varied from 5 to 20 % [22, 27]. R0 resection varied from 20 % to 90 % depending on the method of histopathological examination [28–32]. The most commonly involved margins were the medial margins (60–80 %) and the posterior margins [22]. Hence there is a need to achieve curative intent surgery i.e., R0 resection. Jamieson et al. studied the microscopic positive margin and the prognostic influence. Resection margins were classified as transection margin and mobilization margins [33]. Transection margins includes pancreatic transection and mesopancreas margin close to mesenteric vessels whereas the mobilization margins includes adjacent organs surfaces separated based on embryological development planned and includes anterior, posterior and lateral duodenal margins. These results showed significant poor prognosis for patients with R1 transection margin than for R1 mobilization margins. How much margin is required to decrease the incidence of local recurrence is not yet clear but 1 mm margin may be considered as a potentially curative resection [22].
The term mesopancreas was first proposed by Gockel et al. in the year 2007 in analogy to total mesorectal excision in rectal cancer [13]. They emphasized the need of new surgical classification involving mesopancreas. It can be considered as an anatomical space bounded anteriorly by the the posterior surface of the pancreatic neck, posteriorly by the pancreaticoduodenal coalescence fascia, medially by the mesenteric vessels with nerves, lymphatics and vessels as its contents. It is mandatory to excise the total mesopancreas during the surgery for pancreatic head adenocarcinoma which may increase R0 resections. A cadaveric study by Agarwal et al. found no fibrous sheath or fascia around the structures present in the area of mesopancreas [20].
Technical Modifications Proposed for Better Resection of Mesopancreas
There are various modifications proposed for better resection of the mesopancreas. Pessaux et al. proposed the “hanging maneuver” to achieve negative retroperitoneal margin [34]. Various other modifications like “posterior approach” and “artery first” were proposed because of the high propensity of positivity of the medial margin. Posterior and artery first approach proposed a direct dissection on SMA at its origin from aorta to decrease positive margin at the medial transection side. Weitz et al. proposed a modified artery first approach wherein the artery is identified below the pancreas on the left side of mesentery and dissection is carried upwards and helps in better dissection over the posterior part of artery [35]. Dissection on both sides of artery is not advocated because of increased risk of complications (eg: diarrhea). Horiguchi et al. proposed a mesenteric approach which is similar to the artery first approach [36]. Machado et al. proposed an alternative approach for patients who need portal vein resection which is similar to the Hiedelberg technique [37]. Hirota et al. proposed a “no-touch” technique wherein vessels are dissection first before mobilizing the tumor for pancreatic head tumors. This was proposed mainly for patients undergoing en-bloc superior mesenteric and portal vein resection [28]. Kawabata et al. described a total meso-pancreatoduodenum excision (tMPDe) in which a circumferential lymphadenectomy around the SMA together with mesopancreas was performed. Those patients who underwent tMPDE had no locoregional recurrence and there was increased number of lymph nodes dissected in this group compared with standard PD [38]. “The mesopancreas triangle” was proposed by Adham et al., with its anatomical boundaries formed by the posterior surface of the SMV and PV, a summit over the anterior surface of the aorta between Celiac trunk (CT) and SMA origin, and is limited on either side by the right semi-circumferences of the CT and SMA plexus (Fig. 4) [39]. An aberrant or replaced right hepatic artery is found in 15–20 % of people which can be better identified and dissected by the posterior approach [40]. A recent article by Sanjay.P et al., described 6 different approaches “artery-first”- posterior (through the retroperitoneum), medial uncinate, inferior infracolic (mesenteric), left posterior, superior(lesser sac) and the inferior supracolic(anterior). In the uncinate approach, the inferior pancreaticoduodenal vessels are ligated early and the aberrant right hepatic artery is identified lately, whereas in the posterior approach, the replaced right hepatic artery is identified early [43]. These six approaches gives various options to determine early arterial involvement depending on the location of tumor and helps to decide on resectability before the ‘point of no return’. Though these approaches may help to know early resectability, whether these approaches would increase negative margins of resection, improve disease free survival and increase survival is not yet known.
Surgical Implications of Mesopancreas and its Excision are
-
i.
An existence of definitive well define fascia enclosing the contents of mesopancreas is doubtful unlike as mesorectum
-
ii.
Most of the time it is a flimsy loose areolar tissue and at times it is difficult to define and dissect it preoperatively
-
iii.
But technical modifications like posterior and artery first approach help in better dissection of the mesopancreas
-
iv.
Total mesopancreaticoduodenum(tMPDe) excision helps in excision of tumor enmasse with increased curative(R0) resection
-
v.
Total mesopancreaticoduodenum excision decreases local recurrence
-
vi.
tMPDe helps in increased lymph nodal clearance
-
vii.
Other advantages of posterior and artery first approach are
-
a.
Early selection of patients (to know about resectability)
-
b.
Better delineation of SMA and its abnormalities (eg: aberrant right hepatic artery, Inferior pancreaticoduodenal artery and first jejunal branch)
-
c.
Possibility of en-bloc resection of SMV-PV by no-touch technique
-
d.
Complete clearance of the peripancreatic retroperitoneal tissue [21].
-
a.
At present there is no definitive evidence supporting the superiority of posterior and artery first approach over the standard approach. But there is literature supporting the increased rates of R0 resection by performing a total mesopancreas excision which is better approached by artery first and posterior techniques. Whether total mesopancreas excision would lead to decreased local recurrences and thereby increase survival is not yet known. It needs future clinical trials to answer this question.
Summary
Positive resection margin in pancreatic cancer is associated with poor outcome and is an independent prognostic factor for survival. It is mandatory to perform a total mesopancreatic excision for better curative resection (R0) for pancreatic head cancers. It can be performed by either standard or posterior and artery first approaches. Newer modifications like posterior and artery first approach may help to decrease R1 resection and decrease the risk of local recurrence and improve survival. It needs further prospective trials to confirm the benefits of total mesopancreaticoduodenal excision.
References
Globocan (2008) http://globocan.iarc.fr/factsheet.asp
Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277
Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27:324–329
Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586–594
Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226:248–257
Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10:511–518
Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 72:2118–2123
Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, Schirmacher P, Buchler MW (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15:1651–1660
Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93:1232–1237
Michalski CW, Kleeff J, Wente MN, Diener MK, Buchler MW, Friess H (2007) Systematic review and metaanalysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94:265–273
Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger H, Pederzoli P (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768
Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br J Surg 69:613–616
Gockel I, Domeyer M, Wolloscheck T, Konerding MA, Junginger T (2007) Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol 5:44
Mehrabi A, Mood ZA, Roshanaei N, Fonouni H, Müller SA, Schmied BM, Hinz U, Weitz J, Büchler MW, Schmidt J (2008) Mesohepatectomy as an option for the treatment of central liver tumors. J Am Coll Surg 207(4):499–509
Matsubara T, Ueda M, Nagao N, Takahashi T, Nakajima T, Nishi M (1998) Cervicothoracic approach for total mesoesophageal dissection in cancer of the thoracic esophagus. J Am Coll Surg 187(3):238–245
Gien LT, Covens A (2009) Total mesometrial resection for cancer of the cervix: the future surgical procedure, or oblivion? Lancet Oncol 10(7):644–645
Xie D, Osaiweran H, Liu L, Wang X, Yu C, Tong Y, Hu J, Gong J (2013) Mesogastrium: a fifth route of metastasis in gastric cancer? Med Hypotheses 80(4):498–500
Borghi F, Gattolin A, Garbossa D, Bogliatto F, Garavoglia M, Levi AC (1998) Embryologic bases of extended radical resection in pancreatic cancer. Arch Surg 133(3):297–301
Morton A. Meyers (5th edition). Dynamic Radiology of the Abdomen: Normal and Pathologic Anatomy, Springer (United states of America)
Agrawal MK, Thakur DS, Somashekar U, Chandrakar SK, Sharma D (2010) Mesopancreas: myth or reality? JOP 11(3):230–233
Moldovan SC, Moldovan AM, Dumitraæcu T, Andrei S, Popescu I (2012) The advantages of retropancreatic vascular dissection for pancreatic head cancer with portal/superior mesenteric vein invasion: posterior approach pancreatico-duodenectomy technique and the mesopancreas theory. Chirurgia (Bucur) 107(5):571–578
Popescu I, Dumitrascu T (2011) Total meso-pancreas excision: key point of resection in pancreatic head adenocarcinoma. Hepatogastroenterology 58(105):202–207
Howard JM (1999) Development and progress in resective surgery for pancreatic cancer. World J Surg 23(9):901–906
Kausch W (1912) [Das Carcinom der Papilla duodeni und seine radikale Entfernung] in German. Beitr Z Klin Chir 78:439–486
Whipple AO, Parsons WB, Mullins CR (1935) Treatment of carcioma of the ampulla of Vater. Ann Surg 102(4):763–779
Howard JH (1997) Historical aspects and the future of pancreatoduodenectomy. In: Hanyu F, Takasaki K (eds) Pancreatoduodenectomy. Springer-Verlag, Tokyo, pp 3–10
Gudjonsson B (2002) Survival statistics gone awry: pancreatic cancer, a case in point. J Clin Gastroenterol 35:180–184
Hirota M, Kanemitsu K, Takamori H, Chikamoto A, Tanaka H, Sugita H et al (2010) Pancreatoduodenectomy using a no-touch isolation technique. Am J Surg 199(5):e65–e68
Nagakawa T, Sanada H, Inagaki M, Sugama J, Ueno K, Konishi I et al (2004) Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J Hepatobiliary Pancreat Surg 11(6):402–408
Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD et al (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141(5):610–618
Schmidt CM, Glant J, Winter JM, Kennard J, Dixon J, Zhao Q et al (2007) Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery 142(4):572–578
Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O et al (2008) Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer 14(8):5
Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ et al (2010) Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 251(6):1003–1010
Pessaux P, Rosso E, Panaro F, Marzano E, Oussoultzoglou E, Bachellier P, Jaeck D (2009) Preliminary experience with the hanging maneuver for pancreaticoduodenectomy. Eur J Surg Oncol 35(9):1006–1010
Weitz J, Rahbari N, Koch M, Buchler MW (2010) The “artery first” approach for resection of pancreatic head cancer. J Am Coll Surg 210(2):e1–e4
Horiguchi A, Ishihara S, Ito M, Nagata H, Shimizu T, Furusawa K et al (2007) Pancreatoduodenectomy in which dissection of the efferent arteries of the head of the pancreas is performed first. J Hepatobiliary Pancreat Surg 14(6):575–578
Machado MC, Penteado S, Cunha JE, Jukemura J, Herman P, Bacchella T et al (2001) Pancreatic head tumors with portal vein involvement: an alternative surgical approach. Hepatogastroenterology 48(41):1486–1487
Kawabata Y, Tanaka T, Nishi T, Monma H, Yano S, Tajima Y (2012) Appraisal of a total mesopancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma. Eur J Surg Oncol 38(7):574–579
Adham M, Singhirunnusorn J (2012) Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors. Eur J Surg Oncol 38(4):340–345. doi:10.1016/j.ejso.2011.12.015
Varty PP, Yamamoto H, Farges O, Belghiti J, Sauvanet A (2005) Early retropancreatic dissection during pancreaticoduodenectomy. Am J Surg 189(4):488–491
Gaedcke J, Gunawan B, Grade M, Szoke R, Liersch T, Becker H et al (2010) The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Arch Surg 395(4):451–458
Dumitrascu T, David L, Popescu I (2010) Posterior versus standard approach in pancreatoduodenectomy: a case-match study. Langenbecks Arch Surg 395(6):677–684
Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA (2012) ‘Artery-first’ approaches to pancreatoduodenectomy. Br J Surg 99(8):1027–1035
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chowdappa, R., Challa, V.R. Mesopancreas in Pancreatic Cancer: Where do We Stand – Review of Literature. Indian J Surg Oncol 6, 69–74 (2015). https://doi.org/10.1007/s13193-014-0294-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-014-0294-7